Plenary session 1
Influenza viruses and their pandemic potential
08:00 a.m. – 09:30 a.m.
Session 1
Molecular biology of SARS-CoV-2
10:00 a.m. – 11:30 a.m.
Plenary session 2
Vaccines
01:00 p.m. – 02:30 p.m.
Session 6
Antivirals I
02:45 p.m. – 04:30 p.m.
Plenary session 2.1
Tunneling nanotubes (TNT) in the brain and the link to infectious diseases
04:45 p.m. – 05:15 p.m.
Special session
125 years of virology
05:30 p.m. – 07:00 p.m.
Session 2
One health and wildlife zoonoses
ERINHA AISBL
ISIDORe: Integrated Services for Infectious Disease Outbreak Research
11:45 a.m. – 12:05 p.m.
Session 7
Glycovirology
02:45 p.m. – 04:15 p.m.
Session 3
Virus and cancer
Industrial Session – Moderna
Evolution of the COVID-19 pandemic: Lessons learned and an outlook on the future
11:45 a.m. – 12:45 p.m.
Session 8
Vaccines I
Session 4
Immune therapy in viral infections
10:00 a.m. – 10:50 a.m.
Session 5
dsRNA viruses
10:50 a.m. – 11:40 a.m.
Session 9
Ecology of rodent-borne zoonotic viruses
02:45 p.m. – 03:35 p.m.
Session 10
Virus safety in xenotransplants
03:35 p.m. – 04:25 p.m.
Poster session 1
07:00 p.m. – 08:30 p.m.
5th May 2023